FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Martin Enserink

Research Profile

Phenomena

Disease Outbreaks

Geographic Areas

Activities & Behaviors

Disorders

Living Beings

Concepts & Ideas

21st Century History

Procedures

Chemicals & Drugs

Co-author Network

Publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Martin Enserink (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Martin Enserink
Infectious diseases. Amid heightened concerns, new name for novel coronavirus emerges.
Science (New York, N.Y.) 2013;340(6133):673.
2013: Martin Enserink
Emerging diseases. New coronavirus reveals some of its secrets.
Science (New York, N.Y.) 2013;340(6128):17-8.
2013: Martin Enserink
SARS: chronology of the epidemic.
Science (New York, N.Y.) 2013;339(6125):1266-71.
2013: Martin Enserink
War stories.
Science (New York, N.Y.) 2013;339(6125):1264-8.
2013: David Malakoff; Martin Enserink
Dual use research. New U.S. rules increase oversight of H5N1 studies, other risky science.
Science (New York, N.Y.) 2013;339(6123):1025.
2012: Martin Enserink
Scientific ethics. Final report on Stapel also blames field as a whole.
Science (New York, N.Y.) 2012;338(6112):1270-1.
2012: Martin Enserink
Scientific publishing. As open access explodes, how to tell the good from the bad and the ugly?
Science (New York, N.Y.) 2012;338(6110):1018.
2012: Martin Enserink
Malaria. As drug pilot wraps up, a lively debate about its future.
Science (New York, N.Y.) 2012;338(6108):732-3.
2012: Martin Enserink
Infectious diseases. New XMRV studies bring closure--and fresh dispute.
Science (New York, N.Y.) 2012;337(6101):1441-2.
2012: Mara Hvistendahl; Martin Enserink
GM research. Charges fly, confusion reigns over golden rice study in Chinese children.
Science (New York, N.Y.) 2012;337(6100):1281.
2012: Martin Enserink
Public health. Policy shifts on emergency use of cholera vaccines.
Science (New York, N.Y.) 2012;337(6096):785-6.
2012: Martin Enserink
Scientific ethics. Fraud-detection tool could shake up psychology.
Science (New York, N.Y.) 2012;337(6090):21-2.
2012: Martin Enserink
Avian influenza. For young scientists, a wild ride.
Science (New York, N.Y.) 2012;336(6088):1495.
2012: Martin Enserink
Avian influenza. Public at last, H5N1 study offers insight into virus's possible path to pandemic.
Science (New York, N.Y.) 2012;336(6088):1494-7.
2012: Martin Enserink
Development. First spinoff of African math institute takes root in Senegal.
Science (New York, N.Y.) 2012;336(6081):533.
2012: Martin Enserink; Jon Cohen
Influenza. One H5N1 paper finally goes to press; second greenlighted.
Science (New York, N.Y.) 2012;336(6081):529-30.
2012: Martin Enserink
Biosecurity. Will Dutch allow 'export' of controversial flu study?
Science (New York, N.Y.) 2012;336(6079):285.
2011: Martin Enserink
Infectious diseases. Controversial studies give a deadly flu virus wings.
Science (New York, N.Y.) 2011;334(6060):1192-3.
2011: Martin Enserink
Scientific community. Revolution brings new hopes for Libyan archaeology.
Science (New York, N.Y.) 2011;334(6058):885.
2011: Jon Cohen; Martin Enserink
Virology. False positive.
Science (New York, N.Y.) 2011;333(6050):1694-701.
2011: Martin Enserink
Science funding. European Commission and ERC: 'Let's stay together'.
Science (New York, N.Y.) 2011;333(6040):276.
2011: Martin Enserink
Haiti's cholera outbreak. Cholera linked to U.N. forces, but questions remain.
Science (New York, N.Y.) 2011;332(6031):776-7.
2011: Martin Enserink
Addiction research. Anonymous alcoholic bankrolls trial of controversial therapy.
Science (New York, N.Y.) 2011;332(6030):653.
2011: Martin Enserink
Infectious diseases. 'Breakthrough' deal on flu strains has modest provisions.
Science (New York, N.Y.) 2011;332(6029):525.
2011: Martin Enserink
Infectious diseases. First specific drugs raise hopes for hepatitis C.
Science (New York, N.Y.) 2011;332(6026):159-60.
2011: Martin Enserink
Making her life an open book to promote expanded care.
Science (New York, N.Y.) 2011;331(6024):1549.
2011: Martin Enserink
A push to fight cancer in the developing world.
Science (New York, N.Y.) 2011;331(6024):1548-50.
2011: Martin Enserink
Profile: Helga Nowotny. Keeping Europe's basic research agency on track.
Science (New York, N.Y.) 2011;331(6021):1134-5.
2011: Martin Enserink
Emerging forensics field may hit legal, ethical obstacles.
Science (New York, N.Y.) 2011;331(6019):840.
2011: Martin Enserink
Can this DNA sleuth help catch criminals?
Science (New York, N.Y.) 2011;331(6019):838-40.
2011: Martin Enserink
Epidemiology. Despite sensitivities, scientists seek to solve Haiti's cholera riddle.
Science (New York, N.Y.) 2011;331(6016):388-9.
2011: Martin Enserink
Avian influenza. Transgenic chickens could thwart bird flu, curb pandemic risk.
Science (New York, N.Y.) 2011;331(6014):132-3.
2010: Martin Enserink
Global public health. Scientists' new eradication target: a word in their lexicon.
Science (New York, N.Y.) 2010;330(6012):1738-9.
2010: Martin Enserink
Global public health. What's next for disease eradication?
Science (New York, N.Y.) 2010;330(6012):1736-9.
2010: Martin Enserink
Infectious diseases. Australia to test 'mosquito vaccine' against human disease.
Science (New York, N.Y.) 2010;330(6010):1460-1.
2010: Martin Enserink
Science and society. GM mosquito trial alarms opponents, strains ties in Gates-funded project.
Science (New York, N.Y.) 2010;330(6007):1030-1.
2010: Martin Enserink
Infectious diseases. Haiti's outbreak is latest in cholera's new global assault.
Science (New York, N.Y.) 2010;330(6005):738-9.
2010: Martin Enserink
Environment. After red mud flood, scientists try to halt wave of fear and rumors.
Science (New York, N.Y.) 2010;330(6003):432-3.
2010: Gretchen Vogel; Martin Enserink
Nobel Prizes. Honor for test tube baby pioneer.
Science (New York, N.Y.) 2010;330(6001):158-9.
2010: Martin Enserink
Public health. No vaccines in the time of cholera.
Science (New York, N.Y.) 2010;329(5998):1462-3.
2010: Martin Enserink
Profile: François Nosten. The dour Frenchman on malaria's frontier.
Science (New York, N.Y.) 2010;329(5996):1142-3.
2010: Martin Enserink
Chronic fatigue syndrome. New XMRV paper looks good, skeptics admit--yet doubts linger.
Science (New York, N.Y.) 2010;329(5995):1000.
2010: Martin Enserink
Infectious Diseases. Yellow fever mosquito shows up in Northern Europe.
Science (New York, N.Y.) 2010;329(5993):736.
2010: Martin Enserink
Chronic fatigue syndrome. Conflicting papers on hold as XMRV frenzy reaches new heights.
Science (New York, N.Y.) 2010;329(5987):18-9.
2010: Martin Enserink
Science awards. Efforts to stop UNESCO science award in honor of African dictator.
Science (New York, N.Y.) 2010;328(5982):1089.
2010: Martin Enserink
If artemisinin drugs fail, what's plan B?
Science (New York, N.Y.) 2010;328(5980):846.
2010: Martin Enserink
Malaria's drug miracle in danger.
Science (New York, N.Y.) 2010;328(5980):844-6.
2010: Martin Enserink
As challenges change, so does science.
Science (New York, N.Y.) 2010;328(5980):843.
2010: Martin Enserink
Redrawing Africa's malaria map.
Science (New York, N.Y.) 2010;328(5980):842.
2010: Martin Enserink
Climate change. Scientists ask minister to disavow predecessor's book.
Science (New York, N.Y.) 2010;328(5975):151.
2010: Martin Enserink
Scientific publishing. Elsevier to editor: change controversial journal or resign.
Science (New York, N.Y.) 2010;327(5971):1316.
2010: Martin Enserink
Nutrition science. European food watchdog slashes dubious health claims.
Science (New York, N.Y.) 2010;327(5970):1189.
2010: Martin Enserink
Science and society. Lights! Camera! Science?
Science (New York, N.Y.) 2010;327(5967):778-9.
2010: Martin Enserink
Infectious diseases. Questions abound in Q-fever explosion in the Netherlands.
Science (New York, N.Y.) 2010;327(5963):266-7.
2010: Martin Enserink
Infectious diseases. Humans, animals--it's one health. Or is it?
Science (New York, N.Y.) 2010;327(5963):266-7.
2009: Martin Enserink
France. Sarkozy's 'Grand Loan' bets that research will pay off.
Science (New York, N.Y.) 2009;326(5960):1613.
2009: Martin Enserink; Jon Cohen
Virus of the year. The novel H1N1 influenza.
Science (New York, N.Y.) 2009;326(5960):1607.
2009: Martin Enserink
Science policy. European Union selects unknown for top science post.
Science (New York, N.Y.) 2009;326(5958):1331.
2009: Martin Enserink
Infectious diseases. Farm fungicides linked to resistance in a human pathogen.
Science (New York, N.Y.) 2009;326(5957):1173.
2009: Martin Enserink
Pandemic influenza. Europe reconsiders H1N1 flu shots for children.
Science (New York, N.Y.) 2009;326(5955):922.
2009: Martin Enserink
Swine flu pandemic. Developing countries to get some H1N1 vaccine--but when?
Science (New York, N.Y.) 2009;326(5954):782.
2009: Martin Enserink
Virology. In Holland, the public face of flu takes a hit.
Science (New York, N.Y.) 2009;326(5951):350-1.
2009: Martin Enserink
Swine flu outbreak. Worries about Africa as pandemic marches on.
Science (New York, N.Y.) 2009;325(5941):662.
2009: Martin Enserink
Europe. Fix funding agency's 'original sin,' ERC review panel demands.
Science (New York, N.Y.) 2009;325(5940):523-4.
2009: Martin Enserink
Pandemic influenza. Ferrets shed light on new virus's severity and spread.
Science (New York, N.Y.) 2009;325(5936):17.
2009: Jon Cohen; Martin Enserink
Swine flu. After delays, WHO agrees: the 2009 pandemic has begun.
Science (New York, N.Y.) 2009;324(5934):1496-7.
2009: Martin Enserink
Swine flue outbreak. Swine flu names evolving faster than swine flu itself.
Science (New York, N.Y.) 2009;324(5929):871.
2009: Martin Enserink; Jocelyn Kaiser
Swine flu outbreak. Devilish dilemmas surround pandemic flu vaccine.
Science (New York, N.Y.) 2009;324(5928):702-5.
2009: Jon Cohen; Martin Enserink
Infectious diseases. As swine flu circles globe, scientists grapple with basic questions.
Science (New York, N.Y.) 2009;324(5927):572-3.
2009: Martin Enserink
Scientific publishing. Are you ready to become a number?
Science (New York, N.Y.) 2009;323(5922):1662-4.
2009: Martin Enserink
Drug resistance. A 'wimpy' flu strain mysteriously turns scary.
Science (New York, N.Y.) 2009;323(5918):1162-3.
2009: Martin Enserink
Global health. Some neglected diseases are more neglected than others.
Science (New York, N.Y.) 2009;323(5915):700.
2009: Martin Enserink
Avian influenza. Infection study worries farmers, bird lovers.
Science (New York, N.Y.) 2009;323(5912):324.
2008: Martin Enserink
Malaria. Signs of drug resistance rattle experts, trigger bold plan.
Science (New York, N.Y.) 2008;322(5909):1776.
2008: Martin Enserink
Malaria. Vaccine comes another step closer.
Science (New York, N.Y.) 2008;322(5908):1622-3.
2008: Martin Enserink
Meningitis. Less vaccine can be more.
Science (New York, N.Y.) 2008;322(5907):1449.
2008: Martin Enserink
France. Will French science swallow Zerhouni's strong medicine?
Science (New York, N.Y.) 2008;322(5906):1312.
2008: Martin Enserink
Science in Romania. At home in Bucharest, for better and for worse.
Science (New York, N.Y.) 2008;322(5905):1184-5.
2008: Martin Enserink
Science in Romania. Reaching for the stars in Romania.
Science (New York, N.Y.) 2008;322(5905):1183-5.
2008: Martin Enserink
Global health. Malaria drugs, the Coca-Cola way.
Science (New York, N.Y.) 2008;322(5905):1174.
2008: Jon Cohen; Martin Enserink
Nobel Prize in Physiology or Medicine. HIV, HPV researchers honored, but one scientist is left out.
Science (New York, N.Y.) 2008;322(5899):174-5.
2008: Martin Enserink
Nutrition science. Patents: a recipe for problems?
Science (New York, N.Y.) 2008;322(5898):38.
2008: Martin Enserink
Nutrition science. The peanut butter debate.
Science (New York, N.Y.) 2008;322(5898):36-8.
2008: Martin Enserink
Epidemiology. Lower malaria numbers reflect better estimates and a glimmer of hope.
Science (New York, N.Y.) 2008;321(5896):1620.
2008: Yudhijit Bhattacharjee; Martin Enserink
Anthrax investigation. Six anthrax science questions the FBI has yet to answer.
Science (New York, N.Y.) 2008;321(5892):1027.
2008: Yudhijit Bhattacharjee; Martin Enserink
Anthrax investigation. FBI discusses microbial forensics--but key questions remain unanswered.
Science (New York, N.Y.) 2008;321(5892):1026-7.
2008: Martin Enserink
Anthrax investigation. Full-genome sequencing paved the way from spores to a suspect.
Science (New York, N.Y.) 2008;321(5891):898-9.
2008: Martin Enserink; Yudhijit Bhattacharjee
Bioterrorism. Scientists seek answers, ponder future after anthrax case suicide.
Science (New York, N.Y.) 2008;321(5890):754-5.
2008: Martin Enserink
Science at the Olympics. Does doping work?
Science (New York, N.Y.) 2008;321(5889):627.
2008: Martin Enserink
Scientific meetings. Europe's science gathering draws crowds and long-term funds.
Science (New York, N.Y.) 2008;321(5888):475.
2008: Martin Enserink
Virology. 'Biased' viruses suggest new vaccine strategy for polio and other diseases.
Science (New York, N.Y.) 2008;320(5884):1709.
2008: Martin Enserink
France. Despite protest, CNRS moves toward major shakeup.
Science (New York, N.Y.) 2008;320(5884):1705.
2008: Martin Enserink
Genomics. Read all about it--the first female genome! Or is it?
Science (New York, N.Y.) 2008;320(5881):1274.
2008: Martin Enserink
Universities. Breaking with tradition, France picks future elite schools.
Science (New York, N.Y.) 2008;320(5881):1270.
2008: Martin Enserink
Entomology. A mosquito goes global.
Science (New York, N.Y.) 2008;320(5878):864-6.
2008: Martin Enserink
Tough lessons from golden rice.
Science (New York, N.Y.) 2008;320(5875):468-71.
2008: Martin Enserink
Virology. Coming out of Asia--year in, year out.
Science (New York, N.Y.) 2008;320(5874):311.
2008: Martin Enserink
Virology. Mapmaker for the world of influenza.
Science (New York, N.Y.) 2008;320(5874):310-1.
2008: Martin Enserink
Animal rights. Brazilian scientists battle animal experimentation bans.
Science (New York, N.Y.) 2008;319(5868):1319.
2008: Martin Enserink
Animal disease. Exotic disease of farm animals tests Europe's responses.
Science (New York, N.Y.) 2008;319(5864):710-1.
2008: Martin Enserink
Nutrition science. Lancet and MSF split over malnutrition series.
Science (New York, N.Y.) 2008;319(5863):555.
2008: Martin Enserink
History of science. Dutch universities split over Nobel laureate's rehabilitation.
Science (New York, N.Y.) 2008;319(5862):401.
2008: Martin Enserink
EDUCATION. France launches public health school a l'Anglo-Saxonne.
Science (New York, N.Y.) 2008;319(5862):397.
2007: Martin Enserink
Infectious diseases. Chikungunya: no longer a third world disease.
Science (New York, N.Y.) 2007;318(5858):1860-1.
2007: LESLIE ROBERTS; Martin Enserink
Malaria. Did they really say ... eradication?
Science (New York, N.Y.) 2007;318(5856):1544-5.
2007: Martin Enserink
Influenza. Tense meeting produces some hope for flu-sharing deal.
Science (New York, N.Y.) 2007;318(5855):1361.
2007: Martin Enserink; Dennis Normile
Avian influenza. More bumps on the road to global sharing of H5N1 samples.
Science (New York, N.Y.) 2007;318(5854):1229.
2007: Martin Enserink
Public health. In the HIV era, an old TB vaccine causes new problems.
Science (New York, N.Y.) 2007;318(5853):1059.
2007: Martin Enserink
Combating malaria. Malaria treatment: ACT two.
Science (New York, N.Y.) 2007;318(5850):560-3.
2007: Martin Enserink
European universities. Barroso's brainchild.
Science (New York, N.Y.) 2007;317(5845):1676-7.
2007: Martin Enserink
Biosecurity. Reports blame animal health lab in foot-and-mouth whodunit.
Science (New York, N.Y.) 2007;317(5844):1486.
2007: Martin Enserink
Epidemiology. Tropical disease follows mosquitoes to Europe.
Science (New York, N.Y.) 2007;317(5844):1485.
2007: Martin Enserink
Education. Who ranks the university rankers?
Science (New York, N.Y.) 2007;317(5841):1026-8.
2007: Martin Enserink
Biosecurity. U.K. labs suspected as source of foot-and-mouth outbreak.
Science (New York, N.Y.) 2007;317(5839):732.
2007: Martin Enserink
France. Cancer test dispute pits researcher against a firm she helped create.
Science (New York, N.Y.) 2007;317(5838):585.
2007: Martin Enserink
Entomology. Proven technology may get a makeover.
Science (New York, N.Y.) 2007;317(5836):312-3.
2007: Martin Enserink
Entomology. Welcome to Ethiopia's fly factory.
Science (New York, N.Y.) 2007;317(5836):310-3.
2007: Martin Enserink
The world of undergraduate education. France. Opening up to the rest of the world.
Science (New York, N.Y.) 2007;317(5834):69.
2007: Martin Enserink
Medicine. Initiative aims to merge animal and human health science to benefit both.
Science (New York, N.Y.) 2007;316(5831):1553.
2007: Martin Enserink
Avian influenza. Indonesia earns flu accord at World Health Assembly.
Science (New York, N.Y.) 2007;316(5828):1108.
2007: Martin Enserink
French science. Researchers await changes--and clashes--after Sarkozy's victory.
Science (New York, N.Y.) 2007;316(5826):819.
2007: Martin Enserink
Research funding. European Research Council deluged after first call for proposals.
Science (New York, N.Y.) 2007;316(5825):672.
2007: Martin Enserink
Genetics. Selfish genes could help disease-free mosquitoes spread.
Science (New York, N.Y.) 2007;315(5820):1777-8.
2007: Martin Enserink
Scientific publishing. European Union steps back from open-access leap.
Science (New York, N.Y.) 2007;315(5815):1065.
2007: Martin Enserink
Faith and science. In Europe's mailbag: a glossy attack on evolution.
Science (New York, N.Y.) 2007;315(5814):925.
2007: Martin Enserink
Data sharing. New Swiss influenza database to test promises of access.
Science (New York, N.Y.) 2007;315(5814):923.
2007: Martin Enserink
Virology. From two mutations, an important clue about the Spanish flu.
Science (New York, N.Y.) 2007;315(5812):582.
2007: Dennis Normile; Martin Enserink
Avian influenza. With change in the seasons, bird flu returns.
Science (New York, N.Y.) 2007;315(5811):448.
2006: Martin Enserink
Arms control. Little progress at bioweapons talks.
Science (New York, N.Y.) 2006;314(5806):1673.
2006: Martin Enserink
Stem cell research. A season of generosity...and jeremiads.
Science (New York, N.Y.) 2006;314(5805):1525.
2006: Martin Enserink
European research. Unprecedented budget increase draws faint praise.
Science (New York, N.Y.) 2006;314(5805):1523-5.
2006: Martin Enserink
Drug research. WHO panel weighs radical ideas.
Science (New York, N.Y.) 2006;314(5804):1373.
2006: Martin Enserink
Hervé This profile. The joy of evidence-based cooking.
Science (New York, N.Y.) 2006;314(5803):1235-6.
2006: Martin Enserink
Ilaria Capua profile. Italy's influenza diva.
Science (New York, N.Y.) 2006;314(5801):918-9.
2006: Martin Enserink; Gretchen Vogel
Wildlife conservation. The carnivore comeback.
Science (New York, N.Y.) 2006;314(5800):746-9.
2006: Martin Enserink
France. Presidential hopefuls discover a new issue: science.
Science (New York, N.Y.) 2006;314(5796):39.
2006: Martin Enserink
Influenza. Ground the planes during a flu pandemic? Studies disagree.
Science (New York, N.Y.) 2006;313(5793):1555.
2006: Martin Enserink
Emerging infectious diseases. During a hot summer, bluetongue virus invades northern Europe.
Science (New York, N.Y.) 2006;313(5791):1218-9.
2006: Martin Enserink
Avian influenza. Pushed by an outsider, scientists call for global plan to share flu data.
Science (New York, N.Y.) 2006;313(5790):1026.
2006: Martin Enserink
Infectious diseases. Gastrointestinal virus strikes European cruise ships.
Science (New York, N.Y.) 2006;313(5788):747.
2006: Martin Enserink
France. Cancer chief calls it quits after controversy.
Science (New York, N.Y.) 2006;313(5788):742.
2006: Martin Enserink
Biomedicine. Selling the stem cell dream.
Science (New York, N.Y.) 2006;313(5784):160-3.
2006: Martin Enserink
ETHICS. Blocking a book, Dutch university rekindles furor over Nobelist Debye.
Science (New York, N.Y.) 2006;312(5782):1858.
2006: Martin Enserink
Influenza. What came before 1918? Archaeovirologist offers a first glimpse.
Science (New York, N.Y.) 2006;312(5781):1725.
2006: Martin Enserink
France. Twenty years after Chornobyl, legal fallout lingers.
Science (New York, N.Y.) 2006;312(5779):1455.
2006: Martin Enserink
U.S. courts. 'Disappointed' Butler exhausts appeals.
Science (New York, N.Y.) 2006;312(5777):1120.
2006: Martin Enserink
Alice Dautry profile. After the storm, new Pasteur chief treads softly.
Science (New York, N.Y.) 2006;312(5773):522-3.
2006: Martin Enserink
Genetics. Parasite-resistant mosquitoes: a natural weapon against malaria?
Science (New York, N.Y.) 2006;312(5773):514.
2006: Martin Enserink
France. Chemist claims innocence to spying charge.
Science (New York, N.Y.) 2006;312(5773):512.
2006: Martin Enserink
Oseltamivir becomes plentiful--but still not cheap.
Science (New York, N.Y.) 2006;312(5772):382-3.
2006: Martin Enserink
Research policy. A dose of reform to treat the malaise gripping French science.
Science (New York, N.Y.) 2006;311(5766):1371-2.
2006: Martin Enserink
Avian influenza. As H5N1 keeps spreading, a call to release more data.
Science (New York, N.Y.) 2006;311(5765):1224.
2006: Martin Enserink
Infectious diseases. Massive outbreak draws fresh attention to little-known virus.
Science (New York, N.Y.) 2006;311(5764):1085.
2006: Martin Enserink
Influenza. New study casts doubt on plans for pandemic containment.
Science (New York, N.Y.) 2006;311(5764):1084.
2006: Martin Enserink
Avian influenza. H5N1 moves into Africa, European Union, deepening global crisis.
Science (New York, N.Y.) 2006;311(5763):932.
2006: Martin Enserink
Avian influenza. Amid mayhem in Turkey, experts see new chances for research.
Science (New York, N.Y.) 2006;311(5759):314-5.
2006: Martin Enserink
Avian influenza. More cases in Turkey, but no mutations found.
Science (New York, N.Y.) 2006;311(5758):161.
2005: Martin Enserink
Spongiform diseases. Waiting for the final experiment.
Science (New York, N.Y.) 2005;310(5755):1758.
2005: Martin Enserink
Spongiform diseases. After the crisis: more questions about prions.
Science (New York, N.Y.) 2005;310(5755):1756-8.
2005: Martin Enserink
Epidemiology. Talk on 'underground' bird flu deaths rattles experts.
Science (New York, N.Y.) 2005;310(5753):1409.
2005: Martin Enserink
Influenza. Meeting seeks global consensus, highlights global disparities.
Science (New York, N.Y.) 2005;310(5751):1103.
2005: Martin Enserink
Science and the law. Thomas Butler loses appeal, vows to fight on.
Science (New York, N.Y.) 2005;310(5749):758.
2005: Martin Enserink
Avian influenza. Preaching against the pandemic.
Science (New York, N.Y.) 2005;310(5747):429.
2005: Martin Enserink
Avian influenza. Keeping track of viral air traffic.
Science (New York, N.Y.) 2005;310(5747):428.
2005: Martin Enserink
Public health. Pandemic flu jitters grip Washington.
Science (New York, N.Y.) 2005;310(5746):209.
2005: Martin Enserink
Physiology or medicine. Triumph of the ulcer-bug theory.
Science (New York, N.Y.) 2005;310(5745):34-5.
2005: Martin Enserink
Epidemiology. Horse flu virus jumps to dogs.
Science (New York, N.Y.) 2005;309(5744):2147.
2005: Martin Enserink
Infectious disease. Old drugs losing effectiveness against flu; could statins fill gap?
Science (New York, N.Y.) 2005;309(5743):1976-7.
2005: Martin Enserink; John Bohannon
Hurricane Katrina. Questioning the 'Dutch solution'.
Science (New York, N.Y.) 2005;309(5742):1809.
2005: John Bohannon; Martin Enserink
Hurricane Katrina. Scientists weigh options for rebuilding New Orleans.
Science (New York, N.Y.) 2005;309(5742):1808-9.
2005: Martin Enserink
Infectious diseases. Homeland Security ponders future of its animal disease fortress.
Science (New York, N.Y.) 2005;309(5740):1475.
2005: Martin Enserink
Biodefense. Microbiologist resigns after pitch for antianthrax product.
Science (New York, N.Y.) 2005;309(5740):1475.
2005: Martin Enserink
Research management. New French agency tries out 'Anglo-Saxon style' reviews.
Science (New York, N.Y.) 2005;309(5739):1316-7.
2005: Martin Enserink
Avian influenza. 'Pandemic vaccine' appears to protect only at high doses.
Science (New York, N.Y.) 2005;309(5737):996.
2005: Martin Enserink
Epidemiology. A drug makes it big-but can it deliver?
Science (New York, N.Y.) 2005;309(5736):871.
2005: Martin Enserink
Epidemiology. Drugs, quarantine might stop a pandemic before it starts.
Science (New York, N.Y.) 2005;309(5736):870-1.
2005: Martin Enserink
Research funding. France hatches 67 California wannabes.
Science (New York, N.Y.) 2005;309(5734):547.
2005: Martin Enserink
Avian influenza. Pandemic influenza: global update.
Science (New York, N.Y.) 2005;309(5733):370-1.
2005: Dennis Normile; Martin Enserink
Infectious diseases. Lapses worry bird flu experts.
Science (New York, N.Y.) 2005;308(5730):1849-51.
2005: Martin Enserink
European Union. Political crisis puts Europe's research ambitions in doubt.
Science (New York, N.Y.) 2005;308(5730):1848-9.
2005: Martin Enserink
Infectious diseases. Turf war halts Spain's foot-and-mouth disease studies.
Science (New York, N.Y.) 2005;308(5729):1726.
2005: Martin Enserink
Let's talk about sex--and drugs.
Science (New York, N.Y.) 2005;308(5728):1578.
2005: Martin Enserink
Microbiology. Mosquito-killing fungi may join the battle against malaria.
Science (New York, N.Y.) 2005;308(5728):1531-3.
2005: Martin Enserink
Evolution politics. Is Holland becoming the Kansas of Europe?
Science (New York, N.Y.) 2005;308(5727):1394.
2005: Martin Enserink
Public health. Europe's new disease investigator faces an uphill start.
Science (New York, N.Y.) 2005;308(5727):1394.
2005: Martin Enserink
Smallpox. WHA gives yellow light for variola studies.
Science (New York, N.Y.) 2005;308(5726):1235.
2005: Gretchen Vogel; Martin Enserink
Information sharing. Europe steps into the open with plans for electronic archives.
Science (New York, N.Y.) 2005;308(5722):623-4.
2005: Martin Enserink
Infectious diseases. Crisis of confidence hampers Marburg control in Angola.
Science (New York, N.Y.) 2005;308(5721):489.
2005: Martin Enserink
Influenza. Test kit error is wake-up call for 50-year-old foe.
Science (New York, N.Y.) 2005;308(5721):476.
2005: Martin Enserink
European research. The dos and don'ts of getting an E.U. grant.
Science (New York, N.Y.) 2005;308(5720):344.
2005: Martin Enserink
Infectious diseases. Veterinary scientists shore up defenses against bird flu.
Science (New York, N.Y.) 2005;308(5720):341.
2005: Martin Enserink
Infectious diseases. A puzzling outbreak of Marburg disease.
Science (New York, N.Y.) 2005;308(5718):31-3.
2005: Martin Enserink; Dennis Normile
Infectious diseases. True numbers remain elusive in bird flu outbreak.
Science (New York, N.Y.) 2005;307(5717):1865.
2005: Martin Enserink
Ethics. Doctors pay a high price for priority.
Science (New York, N.Y.) 2005;307(5717):1848-9.
2005: Martin Enserink
Biodefense. Unnoticed amendment bans synthesis of smallpox virus.
Science (New York, N.Y.) 2005;307(5715):1540-1.
2005: Martin Enserink; Jocelyn Kaiser
Biodefense. Has biodefense gone overboard?
Science (New York, N.Y.) 2005;307(5714):1396-8.
2005: Martin Enserink
Infectious diseases. Experts dismiss pig flu scare as nonsense.
Science (New York, N.Y.) 2005;307(5714):1392.
2005: Martin Enserink
French science. Report puts Pasteur move on hold.
Science (New York, N.Y.) 2005;307(5714):1391.
2005: Martin Enserink
Virology. One virus, three names, three claims.
Science (New York, N.Y.) 2005;307(5709):493.
2005: Martin Enserink
Research policy. Facing a revolt, Pasteur board members offer to resign.
Science (New York, N.Y.) 2005;307(5708):333.
2005: Martin Enserink
Infectious diseases. Source of new hope against malaria is in short supply.
Science (New York, N.Y.) 2005;307(5706):33.
2004: Martin Enserink
Influenza. WHO adds more "1918" to pandemic predictions.
Science (New York, N.Y.) 2004;306(5704):2025.
2004: Martin Enserink
Breakthrough of the year. Avian influenza: catastrophe waiting in the wings?
Science (New York, N.Y.) 2004;306(5704):2016.
2004: Martin Enserink
Entomology. An insect's extreme makeover.
Science (New York, N.Y.) 2004;306(5703):1881.
2004: Martin Enserink
Entomology. Can the war on locusts be won?
Science (New York, N.Y.) 2004;306(5703):1880-2.
2004: Martin Enserink
Science policy. Europe advances a plan for merit-based funding.
Science (New York, N.Y.) 2004;306(5702):1669.
2004: Martin Enserink
European Research Council. Only the details are devilish for new funding agency.
Science (New York, N.Y.) 2004;306(5697):796.
2004: Martin Enserink
Infectious diseases. Bird flu infected 1000, Dutch researchers say.
Science (New York, N.Y.) 2004;306(5696):590.
2004: Martin Enserink
Influenza: girding for disaster. Looking the pandemic in the eye.
Science (New York, N.Y.) 2004;306(5695):392-4.
2004: Martin Enserink
Influenza. Crisis underscores fragility of vaccine production system.
Science (New York, N.Y.) 2004;306(5695):385.
2004: Martin Enserink
European Union. The commissioner who listened.
Science (New York, N.Y.) 2004;305(5690):1551.
2004: Martin Enserink
Meetings. Europe clones U.S. science festival.
Science (New York, N.Y.) 2004;305(5689):1387.
2004: Martin Enserink; Jocelyn Kaiser
Virology. Avian flu finds new mammal hosts.
Science (New York, N.Y.) 2004;305(5689):1385.
2004: Martin Enserink
Primate studies. Politics derail European chimp home.
Science (New York, N.Y.) 2004;305(5688):1227.
2004: Martin Enserink
Edward Hammond profile. Activist throws a bright light on institutes' biosafety panels.
Science (New York, N.Y.) 2004;305(5685):768-9.
2004: Martin Enserink
Virology. Tiptoeing around Pandora's Box.
Science (New York, N.Y.) 2004;305(5684):594-5.
2004: Dennis Normile; Martin Enserink
Infectious diseases. Avian influenza makes a comeback, reviving pandemic worries.
Science (New York, N.Y.) 2004;305(5682):321.
2004: Martin Enserink
Climate change. Moscow meeting bogged down in acrimony.
Science (New York, N.Y.) 2004;305(5682):319.
2004: Martin Enserink; Lei Du
SARS. China dumps CDC head, probes lab.
Science (New York, N.Y.) 2004;305(5681):163.
2004: Martin Enserink
Biosecurity. Researchers urge U.S. to keep SARS off select agent list.
Science (New York, N.Y.) 2004;304(5678):1726.
2004: Martin Enserink; Jocelyn Kaiser
Biodefense research. Accidental anthrax shipment spurs debate over safety.
Science (New York, N.Y.) 2004;304(5678):1726-7.
2004: Martin Enserink
Infectious diseases. One year after outbreak, SARS virus yields some secrets.
Science (New York, N.Y.) 2004;304(5674):1097.
2004: Martin Enserink
Higher education. Reinventing Europe's universities.
Science (New York, N.Y.) 2004;304(5673):951-3.
2004: Martin Enserink
Biodefense. Smallpox vaccines: looking beyond the next generation.
Science (New York, N.Y.) 2004;304(5672):809.
2004: Martin Enserink
European expansion. Outwitting TB on the E.U.'s eastern frontier.
Science (New York, N.Y.) 2004;304(5668):199.
2004: Martin Enserink
European expansion. A profound tilt to the east.
Science (New York, N.Y.) 2004;304(5668):198-201.
2004: Martin Enserink
Polio endgame. Wanted: drug for a disappearing disease.
Science (New York, N.Y.) 2004;303(5666):1971.
2004: Martin Enserink
Emerging infectious diseases. A global fire brigade responds to disease outbreaks.
Science (New York, N.Y.) 2004;303(5664):1605.
2004: Martin Enserink
SARS treatment. Interferon shows promise in monkeys.
Science (New York, N.Y.) 2004;303(5662):1273-5.
2004: Martin Enserink
Emerging infectious diseases. Nipah virus (or a cousin) strikes again.
Science (New York, N.Y.) 2004;303(5661):1121.
2004: Eliot Marshall; Martin Enserink
Medicine. Caution urged on SARS vaccines.
Science (New York, N.Y.) 2004;303(5660):944-6.
2003: Martin Enserink; David Malakoff
Scientific community. The final score: 47 to 22.
Science (New York, N.Y.) 2003;302(5653):2062.
2003: Martin Enserink
Scientific community. African study raises ethical issues.
Science (New York, N.Y.) 2003;302(5653):2056.
2003: Martin Enserink; David Malakoff
Scientific community. The trials of Thomas Butler.
Science (New York, N.Y.) 2003;302(5653):2054-63.
2003: Martin Enserink
Breakthrough of the year. SARS: a pandemic prevented.
Science (New York, N.Y.) 2003;302(5653):2045.
2003: David Malakoff; Martin Enserink
Bioterror trial. Butler cleared on most biosecurity charges, convicted of fraud.
Science (New York, N.Y.) 2003;302(5651):1637.
2003: Martin Enserink
Virology. New vaccine and treatment excite Ebola researchers.
Science (New York, N.Y.) 2003;302(5648):1141-2.
2003: Martin Enserink
Bioterrorism. Facing a security deadline, labs get a 'provisional' pass.
Science (New York, N.Y.) 2003;302(5647):962-3.
2003: Martin Enserink
Infectious diseases. Unexplained false alarm may hold lessons.
Science (New York, N.Y.) 2003;302(5646):767.
2003: Martin Enserink; Dennis Normile
Infectious diseases. Search for SARS origins stalls.
Science (New York, N.Y.) 2003;302(5646):766-7.
2003: David Malakoff; Martin Enserink
Biodefense. Researchers await government response to self-regulation plea.
Science (New York, N.Y.) 2003;302(5644):368-9.
2003: Martin Enserink
Infectious diseases. SARS researchers report new animal models.
Science (New York, N.Y.) 2003;302(5643):213.
2003: Martin Enserink
Research oversight. Panel seeks to balance science and security.
Science (New York, N.Y.) 2003;302(5643):206.
2003: Martin Enserink
Infectious diseases. New biodefense splurge creates hotbeds, shatters dreams.
Science (New York, N.Y.) 2003;302(5643):206-7.
2003: Martin Enserink
Infectious diseases. Gates pledges 168 million dollars for malaria research.
Science (New York, N.Y.) 2003;301(5641):1828.
2003: Martin Enserink
Infectious diseases. Singapore lab faulted in SARS case.
Science (New York, N.Y.) 2003;301(5641):1824.
2003: Martin Enserink
Scientific community. Johns Hopkins biodefense pioneers depart en masse.
Science (New York, N.Y.) 2003;301(5641):1824.
2003: Martin Enserink
Thomas Monath profile. Riding the biodefense wave.
Science (New York, N.Y.) 2003;301(5635):912-3.
2003: Martin Enserink
SARS in China. The big question now: will it be back?
Science (New York, N.Y.) 2003;301(5631):299.
2003: Dennis Normile; Martin Enserink
SARS in China. Tracking the roots of a killer.
Science (New York, N.Y.) 2003;301(5631):297-9.
2003: Martin Enserink
SARS in China. China's missed chance.
Science (New York, N.Y.) 2003;301(5631):294-6.
2003: Martin Enserink
Infectious diseases. U.S. monkeypox outbreak traced to Wisconsin pet dealer.
Science (New York, N.Y.) 2003;300(5626):1639.
2003: Martin Enserink
Infectious diseases. Searching for a SARS agenda.
Science (New York, N.Y.) 2003;300(5625):1487-8.
2003: Martin Enserink
Infectious diseases. Clues to the animal origins of SARS.
Science (New York, N.Y.) 2003;300(5624):1351.
2003: Martin Enserink
Albert Osterhaus profile. The virus collector.
Science (New York, N.Y.) 2003;300(5623):1228-9.
2003: Martin Enserink
SARS. Researcher told to stay home after China trip.
Science (New York, N.Y.) 2003;300(5623):1216.
2003: Martin Enserink
Infectious diseases. Smallpox vaccination campaign in the doldrums.
Science (New York, N.Y.) 2003;300(5621):880-1.
2003: Martin Enserink
Infectious diseases. Avian flu outbreak sets off alarm bells.
Science (New York, N.Y.) 2003;300(5620):718.
2003: Martin Enserink
Infectious diseases. WHO wants 21st-century reporting regs.
Science (New York, N.Y.) 2003;300(5620):717-8.
2003: Martin Enserink; Gretchen Vogel
Infectious diseases. Hungry for details, scientists zoom in on SARS genomes.
Science (New York, N.Y.) 2003;300(5620):715-7.
2003: Martin Enserink
Infectious diseases. Calling all coronavirologists.
Science (New York, N.Y.) 2003;300(5618):413-4.
2003: Martin Enserink
Neuroscience. Singapore trial halted, British scientist fired.
Science (New York, N.Y.) 2003;300(5617):233.
2003: Martin Enserink; Gretchen Vogel
Infectious diseases. Deferring competition, global net closes in on SARS.
Science (New York, N.Y.) 2003;300(5617):224-5.
2003: Martin Enserink
Bruce Budowle profile. FBI's top scientist takes the lead in forensic biology.
Science (New York, N.Y.) 2003;300(5616):41-3.
2003: Martin Enserink
War in Iraq. Bracing for Gulf War syndrome II.
Science (New York, N.Y.) 2003;299(5615):1966-7.
2003: Martin Enserink
Infectious diseases. A second suspect in the global mystery outbreak.
Science (New York, N.Y.) 2003;299(5615):1963.
2003: Martin Enserink
Infectious diseases. Scientists chase fast-moving and deadly global illness.
Science (New York, N.Y.) 2003;299(5614):1822.
2003: Martin Enserink
Infectious diseases. Resistant staph finds new niches.
Science (New York, N.Y.) 2003;299(5613):1639-41.
2003: Martin Enserink; Dan Ferber
Microbial forensics. Report spells out how to fight biocrimes.
Science (New York, N.Y.) 2003;299(5610):1164-5.
2003: Martin Enserink
Biosafety labs. The war on bioterror moves west.
Science (New York, N.Y.) 2003;299(5608):814.
2003: Martin Enserink
Biosafety labs. Space suits with that 'je ne sais quoi'.
Science (New York, N.Y.) 2003;299(5608):813.
2003: Martin Enserink
Biosafety labs. The architect behind the new fortresses of science.
Science (New York, N.Y.) 2003;299(5608):812-5.
2003: Martin Enserink
Global health. Bill Gates plans a hit list, with NIH's help.
Science (New York, N.Y.) 2003;299(5607):641.
2003: Martin Enserink
Bioterrorism. Go slow with smallpox shots, panel says.
Science (New York, N.Y.) 2003;299(5606):486-7.
2003: Martin Enserink
Bioterrorism. New look at old data irks smallpox-eradication experts.
Science (New York, N.Y.) 2003;299(5604):181.
2002: Martin Enserink
Public health. Treating vaccine reactions: two lifelines, but no guarantees.
Science (New York, N.Y.) 2002;298(5602):2313.
2002: Jon Cohen; Martin Enserink
Public health. Rough-and-tumble behind Bush's smallpox policy.
Science (New York, N.Y.) 2002;298(5602):2312-6.
2002: Martin Enserink
Breakthrough of the year. Bioterrorism: the calm after the storm.
Science (New York, N.Y.) 2002;298(5602):2300.
2002: Martin Enserink
Science and security. Entering the twilight zone of what material to censor.
Science (New York, N.Y.) 2002;298(5598):1548.
2002: Martin Enserink; Richard Stone
Toxicology. Questions swirl over knockout gas used in hostage crisis.
Science (New York, N.Y.) 2002;298(5596):1150-1.
2002: Jennifer Couzin; Martin Enserink
Women's health. More questions about hormone replacement.
Science (New York, N.Y.) 2002;298(5595):942.
2002: Martin Enserink
Biological and chemical warfare. Secret weapons tests' details revealed.
Science (New York, N.Y.) 2002;298(5593):513-4.
2002: Martin Enserink
Meet the mosquitoes.
Science (New York, N.Y.) 2002;298(5591):95.
2002: Martin Enserink
Lab v. field: the case for studying real-life bugs.
Science (New York, N.Y.) 2002;298(5591):92-3.
2002: Martin Enserink
What mosquitoes want: secrets of host attraction.
Science (New York, N.Y.) 2002;298(5591):90-2.
2002: Martin Enserink
Infectious disease. West Nile's surprisingly swift continental sweep.
Science (New York, N.Y.) 2002;297(5589):1988-9.
2002: Martin Enserink
Confronting terrorism. One year after: hunt for NIH funds fosters collaboration.
Science (New York, N.Y.) 2002;297(5587):1630-1.
2002: Martin Enserink
Women's health. U.K. hormone trial to pause for review.
Science (New York, N.Y.) 2002;297(5582):755-7.
2002: Martin Enserink
Epidemiology. Despite safety concerns, U.K. hormone study to proceed.
Science (New York, N.Y.) 2002;297(5581):492.
2002: Martin Enserink
Women's health. The vanishing promises of hormone replacement.
Science (New York, N.Y.) 2002;297(5580):325-6.
2002: Martin Enserink
Malaria. Ecologists see flaws in transgenic mosquito.
Science (New York, N.Y.) 2002;297(5578):30-1.
2002: Martin Enserink
Biowarfare. Did bioweapons test cause a deadly smallpox outbreak?
Science (New York, N.Y.) 2002;296(5576):2116-7.
2002: Martin Enserink
Fort Detrick. On biowarfare's frontline.
Science (New York, N.Y.) 2002;296(5575):1954-6.
2002: Martin Enserink; Andrew Lawler
National security. Research chiefs hunt for details in proposal for new department.
Science (New York, N.Y.) 2002;296(5575):1944-5.
2002: Martin Enserink
Bioterrorism. In search of a kinder, gentler vaccine.
Science (New York, N.Y.) 2002;296(5573):1594.
2002: Martin Enserink
Bioterrorism. How devastating would a smallpox attack really be?
Science (New York, N.Y.) 2002;296(5573):1592-5.
2002: Martin Enserink
Anthrax sequence. Useful data but no smoking gun.
Science (New York, N.Y.) 2002;296(5570):1002-3.
2002: Martin Enserink
Antiterrorism. USDA closes lab doors to foreign scientists.
Science (New York, N.Y.) 2002;296(5570):996.
2002: Martin Enserink; Eliot Marshall
Biodefense. New anthrax vaccine gets a green light.
Science (New York, N.Y.) 2002;296(5568):639-40.
2002: Martin Enserink
Smallpox vaccines. New cache eases shortage worries.
Science (New York, N.Y.) 2002;296(5565):25-7.
2002: Martin Enserink
Public health. 'Destructionists' fight to keep a dream alive.
Science (New York, N.Y.) 2002;295(5562):2005.
2002: Martin Enserink; Richard Stone
Public health. Dead virus walking.
Science (New York, N.Y.) 2002;295(5562):2001-5.
2002: Martin Enserink
CDC head's resignation expands leadership void.
Science (New York, N.Y.) 2002;295(5560):1624.
2002: Martin Enserink
Microbial genomics. TIGR begins assault on the anthrax genome.
Science (New York, N.Y.) 2002;295(5559):1442-3.
2002: Martin Enserink; Elizabeth Pennisi
Infectious diseases. Researchers crack malaria genome.
Science (New York, N.Y.) 2002;295(5558):1207.
2002: Martin Enserink
Anthrax. 'Borrowed immunity' may save future victims.
Science (New York, N.Y.) 2002;295(5556):777.
2001: Martin Enserink
Infectious diseases. Bed nets prove their mettle against malaria.
Science (New York, N.Y.) 2001;294(5550):2271.
2001: Martin Enserink
A second anthrax genome project.
Science (New York, N.Y.) 2001;294(5548):1812.
2001: Martin Enserink
Anthrax. Can lab sleuths clinch the case?
Science (New York, N.Y.) 2001;294(5548):1811.
2001: Martin Enserink
Taking anthrax's genetic fingerprints.
Science (New York, N.Y.) 2001;294(5548):1810-2.
2001: Martin Enserink; D Malakoff
Bioterrorism. Congress weighs select agent update.
Science (New York, N.Y.) 2001;294(5546):1438.
2001: Martin Enserink
Anthrax. Biodefense hampered by inadequate tests.
Science (New York, N.Y.) 2001;294(5545):1266-7.
2001: Martin Enserink
Prion diseases. U.S. gets tough against chronic wasting disease.
Science (New York, N.Y.) 2001;294(5544):978-9.
2001: D Malakoff; Martin Enserink
Bioterrorism. New law may force labs to screen workers.
Science (New York, N.Y.) 2001;294(5544):971-3.
2001: Martin Enserink
Bioterrorism. Researchers question obsession with Cipro.
Science (New York, N.Y.) 2001;294(5543):759-61.
2001: Martin Enserink
Bioterrorism. This time it was real: knowledge of anthrax put to the test.
Science (New York, N.Y.) 2001;294(5542):490-1.
2001: Martin Enserink
Infectious diseases. Rapid response could have curbed foot-and-mouth epidemic.
Science (New York, N.Y.) 2001;294(5540):26-7.
2001: Martin Enserink
Malaria research. Two new steps toward a 'better mosquito'.
Science (New York, N.Y.) 2001;293(5539):2370-1.
2001: Martin Enserink
Scientific publishing. Peer review and quality: a dubious connection?
Science (New York, N.Y.) 2001;293(5538):2187-8.
2001: Martin Enserink
Virology. Finally, a handle on the hantaviruses.
Science (New York, N.Y.) 2001;293(5534):1414-5.
2001: Martin Enserink
Infectious diseases. Sand fly saliva may be key to new vaccine.
Science (New York, N.Y.) 2001;293(5532):1028.
2001: Martin Enserink
Driving a stake into resurgent TB.
Science (New York, N.Y.) 2001;293(5528):234-5.
2001: Martin Enserink
Virology. Old guard urges virologists to go back to basics.
Science (New York, N.Y.) 2001;293(5527):24-5.
2001: Martin Enserink
Infectious diseases. America's own prion disease?
Science (New York, N.Y.) 2001;292(5522):1641.
2001: Martin Enserink
Infectious diseases. Is the U.S. doing enough to prevent mad cow disease?
Science (New York, N.Y.) 2001;292(5522):1639-41.
2001: Martin Enserink
Infectious diseases. West Nile researchers get ready for round three.
Science (New York, N.Y.) 2001;292(5520):1289-91.
2001: Martin Enserink
Epidemiology. Intensified battle against foot and mouth appears to pay off.
Science (New York, N.Y.) 2001;292(5516):410.
2001: Martin Enserink
Foot-and-mouth disease. Barricading U.S. borders against a devastating disease.
Science (New York, N.Y.) 2001;291(5512):2298-300.
2001: Martin Enserink
AAAS meeting. The flip side of obesity research.
Science (New York, N.Y.) 2001;291(5509):1691.
2001: J Pickrell; Martin Enserink
Foot-and-mouth disease. U.K. outbreak is latest in global epidemic.
Science (New York, N.Y.) 2001;291(5509):1677.
2001: Martin Enserink
Finding the talismans that protect against infection.
Science (New York, N.Y.) 2001;291(5507):1183.
2001: Martin Enserink
Medicine. Restoring faith in the Pentagon.
Science (New York, N.Y.) 2001;291(5505):816.
2001: Martin Enserink
Medicine. Congress explores the scientific fringe.
Science (New York, N.Y.) 2001;291(5505):814.
2001: Martin Enserink
Gulf War illness: the battle continues.
Science (New York, N.Y.) 2001;291(5505):812-7.
2001: Martin Enserink
Malaria. Old movie spawns a new discovery.
Science (New York, N.Y.) 2001;291(5501):24-5.
2000: J Kaiser; Martin Enserink
Environmental toxicology. Treaty takes a POP at the dirty dozen.
Science (New York, N.Y.) 2000;290(5499):2053.
2000: Martin Enserink
Infectious diseases. Has leishmaniasis become endemic in the U.S.?
Science (New York, N.Y.) 2000;290(5498):1881-3.
2000: Martin Enserink
Infectious disease. West Nile drugs, vaccine still years away.
Science (New York, N.Y.) 2000;290(5496):1483.
2000: Martin Enserink
Infectious disease. The enigma of West Nile. .
Science (New York, N.Y.) 2000;290(5496):1482-4.
2000: Martin Enserink
Mosquito engineering. Building a disease-fighting mosquito.
Science (New York, N.Y.) 2000;290(5491):440-1.
2000: Martin Enserink
Bioethics. Helsinki's new clinical rules: fewer placebos, more disclosure.
Science (New York, N.Y.) 2000;290(5491):418-9.
2000: Martin Enserink
Emerging diseases. New arenavirus blamed for recent deaths in California.
Science (New York, N.Y.) 2000;289(5481):842-3.
2000: Martin Enserink
Searching for the mark of Cain.
Science (New York, N.Y.) 2000;289(5479):575-9.
2000: Martin Enserink
Emerging diseases. Malaysian researchers trace Nipah virus outbreak to bats.
Science (New York, N.Y.) 2000;289(5479):518-9.
2000: Martin Enserink
Vaccine development. Radical steps urged to help underserved.
Science (New York, N.Y.) 2000;288(5471):1562-3.
2000: Martin Enserink
Virology. The boom in biosafety labs.
Science (New York, N.Y.) 2000;288(5470):1320-2.
2000: Martin Enserink
Working in the hot zone: Galveston's microbe hunters.
Science (New York, N.Y.) 2000;288(5466):598-600.
2000: Martin Enserink
Psychiatry. Are placebo-controlled drug trials ethical?
Science (New York, N.Y.) 2000;288(5465):416.
2000: Martin Enserink
New York's deadly virus may stage a comeback.
Science (New York, N.Y.) 2000;287(5461):2129-30.
2000: Martin Enserink
Malaria researchers wait for industry to join fight.
Science (New York, N.Y.) 2000;287(5460):1956-8.
2000: Martin Enserink
Global health. Group urges action on Third World drugs.
Science (New York, N.Y.) 2000;287(5458):1571.
2000: Martin Enserink
Biomedical patents. Patent office may raise the bar on gene claims.
Science (New York, N.Y.) 2000;287(5456):1196-7.
2000: Martin Enserink
Scientific community. Controversy claims CDC lab chief.
Science (New York, N.Y.) 2000;287(5456):1187.
2000: Martin Enserink
Human genetics. Start-up claims piece of Iceland gene pie.
Science (New York, N.Y.) 2000;287(5455):951.